Literature DB >> 4177136

Diabetes mellitus in patients with benign prostatic hyperplasia.

J B Bourke, J P Griffin.   

Abstract

Of 51 patients submitted to operation for benign prostatic hyperplasia three (5.9%) were knwon, diabetics and two others had undergone surgery for peptic ulcer. Of the remaining patients half (23 out of 46) were found to be diabetic; 40% (20 patients) had a history of previous cardiac infarction or electrocardiograph evidence of myocardial ischaemia.It is suggested that these findings add further support to the hypothesis that benign prostatic hyperplasia is one manifestation of a relative increase of oestrogen secretion with advancing age.

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 4177136      PMCID: PMC1912667          DOI: 10.1136/bmj.4.5629.492

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  7 in total

1.  URINARY EXCRETION OF ESTRONE, ESTRADIOL AND ESTRIOL BY PATIENTS WITH PROSTATIC CANCER AND BENIGN PROSTATIC HYPERTROPHY.

Authors:  J MARMORSTON; L J LOMBARDO; S M MYERS; H GIERSON; E STERN; C E HOPKINS
Journal:  J Urol       Date:  1965-02       Impact factor: 7.450

2.  Prevalence of glycosuria and diabetes mellitus. A comprehensive survey in an urban community.

Authors:  J HARKNESS
Journal:  Br Med J       Date:  1962-06-02

3.  What makes the prostate grow.

Authors:  W W SCOTT
Journal:  J Urol       Date:  1953-09       Impact factor: 7.450

4.  Oestrogen production by Sertoli cells in the etiology of benign senile hypertrophy of the human prostate; testicular lipoid cell ratio and oestrogen-androgen quotient in human male.

Authors:  G TEILUM
Journal:  Acta Endocrinol (Copenh)       Date:  1950

5.  Diabetes Survey in Bedford 1962.

Authors:  W J Butterfield
Journal:  Proc R Soc Med       Date:  1964-03

6.  Reduced glucose tolerance in elderly human subjects.

Authors:  D H Streeten; M M Gerstein; B M Marmor; R J Doisy
Journal:  Diabetes       Date:  1965-09       Impact factor: 9.461

7.  Hypertension, diabetes mellitus, and blood groups in benign prostatic hypertrophy.

Authors:  J B Bourke; J P Griffin
Journal:  Br J Urol       Date:  1966-02
  7 in total
  9 in total

Review 1.  Benign prostatic hyperplasia.

Authors:  R J Simpson
Journal:  Br J Gen Pract       Date:  1997-04       Impact factor: 5.386

Review 2.  PPARγ: a molecular link between systemic metabolic disease and benign prostate hyperplasia.

Authors:  Ming Jiang; Douglas W Strand; Omar E Franco; Peter E Clark; Simon W Hayward
Journal:  Differentiation       Date:  2011-06-08       Impact factor: 3.880

3.  Benign prostatic enlargement.

Authors:  J P Blandy
Journal:  Br Med J       Date:  1971-01-02

4.  Diabetes associated with prostatic hypertophy and its managemnet in transvesical prostatectomy.

Authors:  G Y Corradi; F Fürst; E Korányi; L Hazay
Journal:  Int Urol Nephrol       Date:  1974       Impact factor: 2.370

5.  Serum testosterone and prostate-specific antigen levels are major risk factors for prostatic volume increase among benign prostatic hyperplasia patients.

Authors:  Gede Wirya Kusuma Duarsa; Yudit Anastasia Sari; Anak Agung Gde Oka; Kadek Budi Santosa; I Wayan Yudiana; Pande Made Wisnu Tirtayasa; Ida Bagus Putra Pramana; Yudhistira Pradnyan Kloping
Journal:  Asian J Urol       Date:  2020-06-07

6.  PPARγ isoforms differentially regulate metabolic networks to mediate mouse prostatic epithelial differentiation.

Authors:  D W Strand; M Jiang; T A Murphy; Y Yi; K C Konvinse; O E Franco; Y Wang; J D Young; S W Hayward
Journal:  Cell Death Dis       Date:  2012-08-09       Impact factor: 8.469

Review 7.  Benign prostatic hyperplasia: a new metabolic disease of the aging male and its correlation with sexual dysfunctions.

Authors:  Giovanni Corona; Linda Vignozzi; Giulia Rastrelli; Francesco Lotti; Sarah Cipriani; Mario Maggi
Journal:  Int J Endocrinol       Date:  2014-02-13       Impact factor: 3.257

8.  Effect of intensive glycemic control and diabetes complications on lower urinary tract symptoms in men with type 1 diabetes: Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) study.

Authors:  Stephen K Van Den Eeden; Aruna V Sarma; Brandy N Rutledge; Patricia A Cleary; John W Kusek; Leroy M Nyberg; Kevin T McVary; Hunter Wessells
Journal:  Diabetes Care       Date:  2009-01-26       Impact factor: 19.112

9.  Impact of type 2 diabetes on lower urinary tract symptoms in men: a cohort study.

Authors:  Stephen K Van Den Eeden; Assiamira Ferrara; Jun Shan; Steven J Jacobsen; Virginia P Quinn; Reina Haque; Charles P Quesenberry
Journal:  BMC Urol       Date:  2013-02-20       Impact factor: 2.264

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.